Table 3.
Demographic and clinical information related to fibromyalgia patients and controls.
| Fibromyalgic Group (N = 31) |
Control Group (N = 31) | |
|---|---|---|
| Sex (male/female) | 0/31 | 0/31 |
| Age (mean ± SD, years) | 42.8 ± 14.04 | 50.0 ± 9.90 |
| Number of participants psychological tests | 19/31 | 19/31 |
| ANA positive | 19/31 | 0/31 |
| ENA positive | 0/31 | 0/31 |
| ACPA positive | 2/31 | 0/31 |
| HAM-A > 17 and HAM-D < 21 | 12/19 | 0/19 |
| HAM-A > 17 and HAM-D > 21 | 7/19 | 0/19 |
| HAM-A < 17 and HAM-D < 21 | 0/19 | 19/19 |
ANA = antinuclear antibodies, ENA = extractable nuclear antigen, ACPA = anti-citrullinated protein antibodies.